NJ Health Officials: Tylenol And Vaccines Safe For Pregnant Parents, Backed By Science

State health authorities are moving to clarify safety concerns for expectant and new parents, reiterating the proven benefits of acetaminophen and recommended vaccinations amid confusion stirred by recent national debates.

The New Jersey Department of Health (NJDOH) and the New Jersey Maternal and Infant Health Innovation Authority (NJMIHIA) jointly issued guidance this week urging pregnant and postpartum individuals, families, and clinicians to rely on established medical recommendations regarding the use of common medications and vaccines. 

Their statement comes after the Trump administration issued a warning on Monday that acetaminophen causes autism. Health experts say the claim is unsubstantiated, as the drug has been used by pregnant people safely for years.

“Acetaminophen has been widely used for decades and is considered safe and effective when used as directed and as needed during pregnancy,” said state Acting Health Commissioner Jeff Brown in a press release. “…[We] urge caution in sharing or acting on unverified health claims.” 

Brown emphasized the department’s commitment to evidence-based policy and ongoing monitoring of research to ensure public guidance reflects the latest credible data.

The agencies highlighted that acetaminophen, most commonly known by the brand name Tylenol, remains a safe and effective option for relieving pain and reducing fever during pregnancy, when used according to a healthcare provider’s instructions.

NJDOH and NJMIHIA point out that there is no current evidence supporting a direct connection. They warn that untreated fever or pain during pregnancy can pose greater risks to both mother and baby. Medication decisions, officials stressed, should always involve consultation with a qualified clinician.

The announcement also emphasized the critical importance of two vaccinations: hepatitis B for newborns, and the COVID-19 vaccine for pregnant and breastfeeding individuals, as well as for children aged six months and older.

These recommendations align with positions held by national authorities, including the American Academy of Pediatrics (AAP), the American College of Obstetricians and Gynecologists (ACOG), and the Society for Maternal-Fetal Medicine (SMFM).

In response to mounting questions, NJMIHIA convened clinicians from the New Jersey Maternal Care Quality Collaborative last week to review updated clinical best practices. The agency underscored that hepatitis B immunization is universally recommended at birth, COVID-19 vaccination is accessible to all New Jerseyans ages six months and up, without a prescription, and acetaminophen continues to be available over the counter.

State officials encourage patients to maintain open communication with their healthcare team and to seek guidance from trusted, qualified sources when making decisions related to maternal and infant health.